论文部分内容阅读
用高舒达治疗68 例危重患者,结果2 例并发上消化道出血,其发生率为2.9% ,而对照组40例中有12 例并发上消化道出血,发生率为30% ,两组比较有显著差异(P< 0.05)。表明高舒达预防和治疗危重患者并发上消化道出血效果显著。
Sixty-eight critically ill patients were treated with Gosoutat, and 2 patients had upper gastrointestinal bleeding, with a rate of 2.9%. Twelve of the 40 patients in the control group had upper gastrointestinal bleeding with a rate of 30%. Two There was significant difference between the two groups (P <0.05). Show that high up to prevention and treatment of critically ill patients with upper gastrointestinal bleeding significantly.